Health and wellness products company USANA Health Sciences (NYSE:USNA) will be announcing earnings results tomorrow after market close. Here's what you need to know.
Last quarter USANA reported revenues of $213.4 million, down 8.5% year on year, missing analyst expectations by 3.2%. It was a weak quarter for the company, with a miss of analysts' revenue estimates and full-year revenue guidance missing analysts' expectations.
Is USANA buy or sell heading into the earnings? Read our full analysis here, it's free.
This quarter analysts are expecting USANA's revenue to decline 6.8% year on year to $212.4 million, improvement on the 14.7% year-over-year decrease in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.52 per share.
Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company missed Wall St's revenue estimates four times over the last two years.
Looking at USANA's peers in the consumer staples segment, some of them have already reported Q4 earnings results, giving us a hint of what we can expect. Post delivered top-line growth of 25.5% year on year, beating analyst estimates by 2.4% and Lamb Weston reported revenues up 35.7% year on year, exceeding estimates by 1.9%. Post traded up 4.8% on the results, and Lamb Weston was down 1.4%.
Investors in the consumer staples segment have had steady hands going into the earnings, with the stocks down on average 0.4% over the last month. USANA is down 7.4% during the same time, and is heading into the earnings with analyst price target of $68, compared to share price of $47.2.
One way to find opportunities in the market is to watch for generational shifts in the economy. Almost every company is slowly finding itself becoming a technology company and facing cybersecurity risks and as a result, the demand for cloud-native cybersecurity is skyrocketing. This company is leading a massive technological shift in the industry and with revenue growth of 70% year on year and best-in-class SaaS metrics it should definitely be on your radar.
Join Paid Stock Investor Research
Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here.
The author has no position in any of the stocks mentioned.